All these results suggested that the cytokine in our array could reflect different BM microenvironments in AML and healthy controls; cytokine–cytokine receptor interaction and JAK-STAT signaling might play an important role in leukemogenesis and immune response, which also provides new potential target for AML therapy. The gene discussed is SOAT1; the disease is acute myeloid leukemia.